Loading...
Market
Number of patients diagnosed using UCL's AI blood test in UK by end of 2024?
5
Resolution / Starting Odds
0-1000 • 25%
1001-5000 • 25%
5001-10000 • 25%
10001+ • 25%
Official reports from NHS or UCL
Story
UCL's AI-Powered Blood Test Predicts Parkinson's Seven Years Before Symptoms Using Protein Biomarkers
Jun 18, 2024, 03:52 PM
Researchers have developed an AI-powered blood test that can predict Parkinson's disease up to seven years before symptoms appear. The test, created by scientists at University College London (UCL), identifies a biological signature of the disease by analyzing a panel of eight protein biomarkers, including alpha-synuclein. This breakthrough could revolutionize early diagnosis and treatment of Parkinson's, a degenerative condition caused by the death of nerve cells in the brain that controls movement. The findings, published in Nature Communications, offer hope for better management of the disease, which affects approximately 153,000 people in the UK.
View original story
Similar markets
Less than 100,000 • 33%
100,000 to 200,000 • 33%
More than 200,000 • 33%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
High adoption (75%+ countries) • 25%
Moderate adoption (50-74% countries) • 25%
Low adoption (25-49% countries) • 25%
Minimal adoption (<25% countries) • 25%
1-50 • 25%
51-100 • 25%
101-150 • 25%
151 or more • 25%
Successful with no major issues • 25%
Successful with some issues • 25%
Unsuccessful • 25%
Trials not completed • 25%
Yes • 50%
No • 50%
Less than 10,000 • 25%
10,000 to 20,000 • 25%
20,001 to 30,000 • 25%
More than 30,000 • 25%
Less than 10,000 • 25%
10,000 to 20,000 • 25%
20,000 to 30,000 • 25%
More than 30,000 • 25%
Less than 200 • 25%
200 to 400 • 25%
400 to 600 • 25%
More than 600 • 25%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%